Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Sequenom raises $136.5 million in IPO

SQNM raised $136.5 million through the sale of 5.25

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE